Report post

How much does Translate Bio (TBIO) stock cost?

Translate Bio is exploring the potential use of mRNA on diseases that affect the liver. The deal values TBIO stock at $38 per share in cash. The price represents a 56% premium to the volume-weighted average price of TBIO stock over the past 60 days. Sanofi expects the tender offer to begin later this month.

What is Translate Bio?

TRANSLATE BIO, INC. Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins.

When did the tender offer for Translate Bio stock expire?

The tender offer for all of the outstanding shares of Translate Bio common stock expired as scheduled at one minute after 11:59 p.m., Eastern Time, on Monday, September 13, 2021.

The World's Leading Crypto Trading Platform

Get my welcome gifts